Can macrocytosis reflect folate or vitamin B12–related impairment of one‑carbon metabolism and homocysteine remethylation?

Macrocytosis—a state where the mean corpuscular volume (MCV) of red blood cells exceeds 100 fL—is a well-established clinical indicator of disruptions in one-carbon metabolism, specifically involving folate (vitamin B9) and vitamin B12. These nutrients are essential for the biochemical pathways that govern both DNA synthesis and the regulation of homocysteine levels.

Clinical and mechanistic evidence

The link between macrocytosis and impaired one-carbon metabolism is rooted in the "megaloblastic" process of blood cell formation.

• DNA Synthesis Inhibition: Folate and B12 are required to synthesize deoxythymidine triphosphate (dTTP). When these nutrients are deficient, DNA replication in erythroid precursors is delayed during the S-phase.
• Nuclear-Cytoplasmic Asynchrony: While DNA synthesis stalls, RNA and protein production (hemoglobin) continue normally. This results in larger-than-normal cells—macrocytes—that are released into the bloodstream.
• Diagnostic Sensitivity: Although macrocytosis is highly specific (90–93%) for these metabolic disturbances, its sensitivity is relatively low (10–20% in some cohorts). Up to 50% of patients with confirmed nutrient deficiencies may not exhibit macrocytosis, often due to concurrent iron deficiency or early-stage disease.

Homocysteine remethylation

Folate and vitamin B12 are obligatory cofactors in the remethylation of homocysteine back into the amino acid methionine.

• Enzymatic Role: Methionine synthase (MS) facilitates this conversion. Folate (as 5-methyltetrahydrofolate) serves as the methyl donor, while B12 (as methylcobalamin) acts as the essential cofactor.
• The "Methylfolate Trap": A deficiency in B12 can lead to folate being trapped in an unusable form, indirectly halting the remethylation process.
• Impact on Levels: Disruption of these pathways is a primary cause of hyperhomocysteinemia. Studies demonstrate that supplementing with folate and B12 can reduce plasma homocysteine levels by 25% to 33%, confirming their central role in this metabolic cycle.

Bottom line

Macrocytosis is a scientifically validated marker of impaired one-carbon metabolism. While it frequently reflects deficiencies in folate or B12—nutrients that are essential for homocysteine remethylation—the absence of an elevated MCV does not definitively rule out these metabolic imbalances.